e
26
20
2
4e
16
9
7
0
19
1
49
2
2
1d
3a
Back to Top
2c
d
2
1e
e
8
1b
1d
18
89
2b
1d
2 29
1d
25
2b
Cecile M Denis
4fResearch Assistant Professor of Psychiatry
7
61
Department: Psychiatry
4
1
b
1d
46
Contact information
46
4
3
3
3
2
4
b
1f
46
Department of Psychiatry
28 HIV Prevention Research Division
16 3535 Market St
2d Suite 4000
Philadelphia, PA 19104
26
28 HIV Prevention Research Division
16 3535 Market St
2d Suite 4000
Philadelphia, PA 19104
2e
Office: 267-265-6337
3e Lab: 215-746-7355
18
9b
12
3e Lab: 215-746-7355
18
13
Education:
21 7 BS 19 (Biochemistry) c
37 University of Poitiers, France, 2000.
21 8 MSc 19 (Biochemistry) c
41 University of Liverpool, United Kingdom , 2001.
21 8 MSc 32 (Neuropsychopharmacology and Addiction) c
38 University of Bordeaux, France , 2002.
21 b Degree 28 (Statistics and Epidemiology) c
37 University of Bordeaux, France, 2003.
21 8 PhD 25 (Psychology and Addiction) c
38 University of Bordeaux, France , 2009.
c
3
3
21
21 7 BS 19 (Biochemistry) c
37 University of Poitiers, France, 2000.
21 8 MSc 19 (Biochemistry) c
41 University of Liverpool, United Kingdom , 2001.
21 8 MSc 32 (Neuropsychopharmacology and Addiction) c
38 University of Bordeaux, France , 2002.
21 b Degree 28 (Statistics and Epidemiology) c
37 University of Bordeaux, France, 2003.
21 8 PhD 25 (Psychology and Addiction) c
38 University of Bordeaux, France , 2009.
c
1f
Post-Graduate Training
24 8c Post-doctoral fellow, Addiction Psychiatry Lab, USR CNRS 3413 SANPsy, University of Bordeaux, Bordeaux, France, 2009-2011.
24 be Post-doctoral fellow, Center for Studies of Addiction, Department of Psychiatry, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA (USA), 2011-2016.
c
3
3
8d
Permanent link24 8c Post-doctoral fellow, Addiction Psychiatry Lab, USR CNRS 3413 SANPsy, University of Bordeaux, Bordeaux, France, 2009-2011.
24 be Post-doctoral fellow, Center for Studies of Addiction, Department of Psychiatry, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA (USA), 2011-2016.
c
2 29
21
1e
1d
24
76
1e substance use disorder
c HIV
1a Infectious disease
15 Mental health
14 Study design
11 Statistics
e 29
27
Description of Research Expertise
1a Addiction1e substance use disorder
c HIV
1a Infectious disease
15 Mental health
14 Study design
11 Statistics
e 29
23
1b5 21. Denis C., Azzoni L., Trias V., Thu T.H., Dang Thi Nhat V., Sylla B., Daulouède J-P., Raguin G., Metzger D, Montaner L.: MOUD preferences in participants randomized in methadone, buprenorphine and extended-release naltrexone (AMOHI study, Vietnam). 87th Annual Meeting - College on Problems of Drug Dependence; June 14-18, 2025; New Orleans, LA, USA June 2025.
1b3 22. Metzger D, Azzoni L., Denis C., Papasavvas E., Morris J., Trias V., Thu T.H., Dang Thi Nhat V., Le Chi T., Scott-Algara D., Montaner L. : Effect of Methamphetamine use on immune parameters in people with opioid use disorder and HIV infection initiating treatment in Vietnam. 87th Annual Meeting - College on Problems of Drug Dependence; June 14-18, 2025; New Orleans, LA, USA 1f June 2025.
18b Anwar I, Faye A, Donadille C, Briand Madrid L, Lalanne L, Jauffret-Roustide M, Auriacombe M, Roux P; COSINUS Study Group*. * co-I of the COSINUS Study Group: Gender-based factors associated with hepatitis C testing in people who inject drugs: results from the French COSINUS cohort. BMJ Open. 15(3): e091707, March 2025.
1c5 Roux P, Faye A, Sagaon-Teyssier L, Donadille C, Briand Madrid L, Carrieri MP, Maradan G, Jauffret-Roustide M, Lalanne L, Auriacombe M; COSINUS study group. * co-I of the COSINUS Study Group: Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study. Drug Alcohol Rev. 44(1), January 2025.
204 Lalanne L, Davalos JR, Audran M, Hamelin N, Chauvin C, Briand-Madrid L, Kervran C, Kirchherr S, Auriacombe M, Roux P, Jauffret-Roustide M; Cosinus Study Group. * co-I of the COSINUS Study Group: Medications for Opioid Use Disorder in People Who Inject Substances: Reflection on the Potential Place of Morphine Sulfate as Substitution Treatment? Results of COSINUS Cohort Study. Subst Use Misuse. Subst Use Misuse (eds.). 60(3): 393-402, 2025.
1a0 Perez-Brumer A, Schmidt R, Kennedy R, Lake JE, Villarreal YR, Bornstein S, Kuo I, Nieto O, Franks J, Denis C, El-Bassel N, Shoptaw S, Davidson P, Smith LR.: Centering autonomy and choice to support oral PrEP utilization among people who inject drugs: qualitative lessons from HPTN 094 INTEGRA. Addict Sci Clin Pract. 19(1): 92, December 2024.
1a9 29. Smith LR, Perez-Brumer A, Nicholls M, Harris J, Allen Q, Padilla A, Yates A, Samore E, Kennedy R, Kuo I, Lake JE, Denis C, Goodman-Meza D, Davidson P, Shoptaw S, El-Bassel N; HPTN 094 study protocol team. : A data-driven approach to implementing the HPTN 094 complex intervention INTEGRA in local communities. Implement Sci. 19(1): 39, June 2024.
1a7 Smith, L.R., Perez-Brumer, A., Nicholls, M., Harris, J., Allen, Q., Padilla, A., Yates, A., Samore, E., Kennedy, R., Kuo, I., Lake, J.E., Denis, C., Goodman-Meza, D., Davidson, P., Shoptaw, S., El-Bassel, N. : A data-driven approach to implementing the HPTN 094 complex intervention INTEGRA in local communities. Implement Sci. 19(1): 39, June 2024.
1ae Azzoni L., Sovereign A., Holbert R., Hiserodt E., Fair M., Ellison R., Denis C., Jessop A., Mounzer K., Metzger D., Gerona R., Montaner L. : LC-QTOF/MS analysis of plasma samples confirms widespread multi-class polydrug use in Philadelphia, Pennsylvania. 86th Annual Meeting - College on Problems of Drug Dependence; June 15-19, 2024; Montreal, Canada 2024.
2c
7
1d
1f
Selected Publications
1a3 Lalanne L, Kirchherr S, Audran M, de Dinechin S, Hamelin N, Chauvin C, Briand-Madrid L, Kervran C, Auriacombe M, Roux P, Jauffret-Roustide M; COSINUS study group. * co-I of the COSINUS Study Group: Episodic memory and inhibitory control in people who inject substances results of cohort COSINUS study. BMC Psychiatry 25(1): 853, September 2025.1b5 21. Denis C., Azzoni L., Trias V., Thu T.H., Dang Thi Nhat V., Sylla B., Daulouède J-P., Raguin G., Metzger D, Montaner L.: MOUD preferences in participants randomized in methadone, buprenorphine and extended-release naltrexone (AMOHI study, Vietnam). 87th Annual Meeting - College on Problems of Drug Dependence; June 14-18, 2025; New Orleans, LA, USA June 2025.
1b3 22. Metzger D, Azzoni L., Denis C., Papasavvas E., Morris J., Trias V., Thu T.H., Dang Thi Nhat V., Le Chi T., Scott-Algara D., Montaner L. : Effect of Methamphetamine use on immune parameters in people with opioid use disorder and HIV infection initiating treatment in Vietnam. 87th Annual Meeting - College on Problems of Drug Dependence; June 14-18, 2025; New Orleans, LA, USA 1f June 2025.
18b Anwar I, Faye A, Donadille C, Briand Madrid L, Lalanne L, Jauffret-Roustide M, Auriacombe M, Roux P; COSINUS Study Group*. * co-I of the COSINUS Study Group: Gender-based factors associated with hepatitis C testing in people who inject drugs: results from the French COSINUS cohort. BMJ Open. 15(3): e091707, March 2025.
1c5 Roux P, Faye A, Sagaon-Teyssier L, Donadille C, Briand Madrid L, Carrieri MP, Maradan G, Jauffret-Roustide M, Lalanne L, Auriacombe M; COSINUS study group. * co-I of the COSINUS Study Group: Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study. Drug Alcohol Rev. 44(1), January 2025.
204 Lalanne L, Davalos JR, Audran M, Hamelin N, Chauvin C, Briand-Madrid L, Kervran C, Kirchherr S, Auriacombe M, Roux P, Jauffret-Roustide M; Cosinus Study Group. * co-I of the COSINUS Study Group: Medications for Opioid Use Disorder in People Who Inject Substances: Reflection on the Potential Place of Morphine Sulfate as Substitution Treatment? Results of COSINUS Cohort Study. Subst Use Misuse. Subst Use Misuse (eds.). 60(3): 393-402, 2025.
1a0 Perez-Brumer A, Schmidt R, Kennedy R, Lake JE, Villarreal YR, Bornstein S, Kuo I, Nieto O, Franks J, Denis C, El-Bassel N, Shoptaw S, Davidson P, Smith LR.: Centering autonomy and choice to support oral PrEP utilization among people who inject drugs: qualitative lessons from HPTN 094 INTEGRA. Addict Sci Clin Pract. 19(1): 92, December 2024.
1a9 29. Smith LR, Perez-Brumer A, Nicholls M, Harris J, Allen Q, Padilla A, Yates A, Samore E, Kennedy R, Kuo I, Lake JE, Denis C, Goodman-Meza D, Davidson P, Shoptaw S, El-Bassel N; HPTN 094 study protocol team. : A data-driven approach to implementing the HPTN 094 complex intervention INTEGRA in local communities. Implement Sci. 19(1): 39, June 2024.
1a7 Smith, L.R., Perez-Brumer, A., Nicholls, M., Harris, J., Allen, Q., Padilla, A., Yates, A., Samore, E., Kennedy, R., Kuo, I., Lake, J.E., Denis, C., Goodman-Meza, D., Davidson, P., Shoptaw, S., El-Bassel, N. : A data-driven approach to implementing the HPTN 094 complex intervention INTEGRA in local communities. Implement Sci. 19(1): 39, June 2024.
1ae Azzoni L., Sovereign A., Holbert R., Hiserodt E., Fair M., Ellison R., Denis C., Jessop A., Mounzer K., Metzger D., Gerona R., Montaner L. : LC-QTOF/MS analysis of plasma samples confirms widespread multi-class polydrug use in Philadelphia, Pennsylvania. 86th Annual Meeting - College on Problems of Drug Dependence; June 15-19, 2024; Montreal, Canada 2024.
2c